We have located links that may give you full text access.
Comparison of the Cervex-Brush alone to Cytobrush plus Cervex-Brush for detection of cervical dysplasia in women with a transformation zone type 3.
INTRODUCTION: Twenty percent of colposcopic assessments are inadequate due to a type 3 transformation zone (TZ3). In the absence of colposcopic or histological assessment, subsequent management is guided by the referral screening test. In the UK routine cervical screening is completed by a Cervex-Brush alone. This study examines the effectiveness of a cytobrush in addition to a standard Cervex-Brush when used in TZ3 assessment.
METHODOLOGY: An 18 month diagnostic accuracy study in a single NHS Trust. Women with a TZ3 booked for LLETZ with a referral cytology of high risk HPV and squamous dyskaryosis were recruited. Immediately prior to LLETZ a Cervex-Brush plus Cytobrush liquid-based cytology sample was taken. Presence of endocervical cells were compared. Predictability of CIN2+ was by blind standardised reporting of the LLETZ histology.
RESULTS: One hundred and five women were recruited from a total eligible population of 153 cases (68.8%). Endocervical cell yield was increased with the Cervex-Brush plus Cytobrush when compared to the Cervex-Brush alone (99.1% vs 79.1%, p<0.001). Irrespective of cytological grade, age or parity, there was no difference in predictability of CIN2+ between sampling methods CONCLUSIONS: When compared to Cervex-Brush sampling alone, the addition of a Cytobrush improves endocervical sampling but does not improve cytological predictability of CIN2+ in women with a TZ3. These data suggest that women who will reliably attend for cytological follow-up can be safely referred to primary care for a Cervex-Brush alone. This article is protected by copyright. All rights reserved.
METHODOLOGY: An 18 month diagnostic accuracy study in a single NHS Trust. Women with a TZ3 booked for LLETZ with a referral cytology of high risk HPV and squamous dyskaryosis were recruited. Immediately prior to LLETZ a Cervex-Brush plus Cytobrush liquid-based cytology sample was taken. Presence of endocervical cells were compared. Predictability of CIN2+ was by blind standardised reporting of the LLETZ histology.
RESULTS: One hundred and five women were recruited from a total eligible population of 153 cases (68.8%). Endocervical cell yield was increased with the Cervex-Brush plus Cytobrush when compared to the Cervex-Brush alone (99.1% vs 79.1%, p<0.001). Irrespective of cytological grade, age or parity, there was no difference in predictability of CIN2+ between sampling methods CONCLUSIONS: When compared to Cervex-Brush sampling alone, the addition of a Cytobrush improves endocervical sampling but does not improve cytological predictability of CIN2+ in women with a TZ3. These data suggest that women who will reliably attend for cytological follow-up can be safely referred to primary care for a Cervex-Brush alone. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app